01 5E Keppra
02 6Keppra
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 839
2018 Revenue in Millions : 860
Growth (%) : -2
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 953
2019 Revenue in Millions : 931
Growth (%) : 2
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 406
2019 Revenue in Millions : 444
Growth (%) : -9
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 1,068
2020 Revenue in Millions : 953
Growth (%) : 23
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 777
2021 Revenue in Millions : 1,068
Growth (%) : -27
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 686
2022 Revenue in Millions : 776
Growth (%) : 14
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 261
2015 Revenue in Millions : 207
Growth (%) : 26
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 324
2016 Revenue in Millions : 274
Growth (%) : 19
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 363
2017 Revenue in Millions : 304
Growth (%) : 19%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 435
2018 Revenue in Millions : 375
Growth (%) : 16
LOOKING FOR A SUPPLIER?